Further research into the regulation, function, and therapeutic targeting of VEGF splice variants will undoubtedly continue to shed light on the pathophysiology of angiogenesis and offer new hope to patients struggling with HNSCC. The gene discussed is VEGFA; the disease is head and neck squamous cell carcinoma.